Try our beta test site
30 studies found for:    danoprevir | Studies received from 01/01/2005 to 12/12/2020
Show Display Options
Rank Status Study
1 Completed Safety, Tolerability and Pharmacokinetics of Danoprevir/r in Healthy Volunteers China
Condition: Healthy
Interventions: Drug: Danoprevir;   Drug: Ritonavir;   Drug: Placebo
2 Completed A Study of Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir and Raltegravir in Healthy Volunteers
Condition: Healthy Volunteer
Interventions: Drug: danoprevir;   Drug: raltegravir;   Drug: ritonavir
3 Active, not recruiting Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III
Condition: Chronic Hepatitis C
Interventions: Drug: Danoprevir;   Drug: Ritonavir;   Drug: peginterferon alfa-2a;   Drug: RBV
4 Active, not recruiting Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China II
Condition: Chronic Hepatitis C
Interventions: Drug: Danoprevir;   Drug: Ritonavir;   Drug: peginterferon alfa-2a;   Drug: Ribavirin (RBV)
5 Completed A Drug-Drug Interaction Study Between Danoprevir/Low-Dose Ritonavir and Cyclosporine in Healthy Volunteers
Condition: Healthy Volunteer
Interventions: Drug: cyclosporine;   Drug: danoprevir;   Drug: ritonavir
6 Active, not recruiting Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan
Condition: Chronic Hepatitis C
Interventions: Drug: Ravidasvir;   Drug: Danoprevir;   Drug: Ritonavir;   Drug: Ribavirin
7 Active, not recruiting Pharmacokinetics and Safety of Ravidasvir and Danoprevir/r in Healthy Volunteers China
Condition: Healthy
Interventions: Drug: Ravidasvir;   Drug: Danoprevir;   Drug: Ritonavir;   Drug: Placebo
8 Completed A Study of Drug-Drug Interaction Between Darunavir and Danoprevir Administered Together With Low-Dose Ritonavir in Healthy Volunteers
Condition: Healthy Volunteer
Interventions: Drug: danoprevir;   Drug: darunavir;   Drug: ritonavir
9 Completed A Study of Potential Drug-Drug Interaction Between Efavirenz and Danoprevir With Low Dose Ritonavir in Healthy Volunteers
Condition: Healthy Volunteer
Interventions: Drug: danoprevir;   Drug: efavirenz;   Drug: ritonavir
10 Completed A Study on the Interaction Between Danoprevir/Ritonavir and Methadone
Condition: Healthy Volunteer
Interventions: Drug: danoprevir;   Drug: methadone;   Drug: ritonavir
11 Completed A Study of The Relative Bioavailability of Ritonavir-Boosted Danoprevir Fixed Dose Combination Tablets in Healthy Volunteers
Condition: Healthy Volunteer
Interventions: Drug: danoprevir;   Drug: ritonavir
12 Completed A Study to Evaluate the Effect of Danoprevir/Ritonavir on the Pharmacokinetics of Escitalopram and S-Demethylcitalopram in Healthy Volunteers
Condition: Healthy Volunteer
Interventions: Drug: danoprevir;   Drug: escitalopram;   Drug: ritonavir
13 Completed A Study of Danoprevir in Healthy Volunteers And Patients With Hepatic Impairment
Condition: Healthy Volunteer
Interventions: Drug: danoprevir;   Drug: ritonavir
14 Completed A Study to Evaluate The Effects of Two Different Meal Types, Omeprazole And Ranitidine On Danoprevir Pharmacokinetics When Coadministered With Ritonavir in Healthy Volunteers
Condition: Healthy Volunteer
Interventions: Drug: danoprevir;   Drug: omeprazole;   Drug: ranitidine;   Drug: ritonavir
15 Completed A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir
Condition: Healthy Volunteer
Interventions: Drug: atazanavir;   Drug: danoprevir;   Drug: ritonavir;   Drug: tenofovir disoproxil fumarate
16 Completed A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Copegus;   Drug: Pegasys;   Drug: RO5024048;   Drug: danoprevir;   Drug: ritonavir
17 Completed A Study of Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis
Condition: Hepatitis C, Chronic
Interventions: Drug: danoprevir + ritonavir;   Drug: peginterferon alfa-2a [Pegasys];   Drug: ribavirin [Copegus]
18 Completed A Study of Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis
Condition: Hepatitis C, Chronic
Interventions: Drug: RO5024048;   Drug: danoprevir;   Drug: peginterferon alfa-2a [Pegasys];   Drug: ribavirin;   Drug: ritonavir
19 Completed A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy Volunteers
Condition: Healthy Volunteer
Interventions: Drug: danoprevir;   Drug: placebo;   Drug: ritonavir
20 Completed A Safety And Pharmacokinetic Study of Setrobuvir Alone and In Combination With Ritonavir-Boosted Danoprevir in Subjects With Mild Hepatic Impairment Compared to Healthy Controls
Condition: Healthy Volunteer
Interventions: Drug: danoprevir;   Drug: ritonavir;   Drug: setrobuvir

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.